ERA Congress 2025 Late-Breaking Collection

  • Published:  05 June 2025

  • Likes: 

    Heart Icon

    1

Up Next

ERA Congress 2025 Late-Breaking Collection

  • Published:  05 June 2025

  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
About the episode

ERA 2025 - Prof David Wheeler (University College London, London, UK) joins us to discuss outcomes from real-world data investigating cardiovascular and renal outcomes in patients with DKD.



Interview Questions:
1. How do real-world cardiovascular and renal outcomes compare to clinical trial results, and which data sources are giving us the best insights into DKD outcomes?
2. What's the biggest gap between DKD guidelines and actual prescribing for cardiovascular and renal protection?
3. Can we optimise for both cardiovascular and renal protection simultaneously in DKD patients?
4. What does real-world data tell us about sequencing therapies for optimal cardiovascular and renal outcomes?
5. How should cardiology and nephrology collaborate differently based on current real-world cardiovascular and renal outcome data?

 

Recorded on-site at ERA in Vienna, 2025.

Editors: Jordan Rance, Yazmin Sadik
Videographers: David Ben-Harosh, Tom Green, Dan Brent

Support: This is an independent interview produced by Radcliffe CVRM.

Overview

Keep up-to-date with the late-breaking presentations from the European Renal Association's 62nd congress, taking place from 4th to 7th June 2025 in Vienna. With Expert Interviews focusing on the applicability of the latest data and Highlights summarising the key take-aways, our video collection has you covered.

More from this programme

Part 1

Expert Interviews

7 sessions
Guideline-Based Management of CKD and Associated Risk of Cardio-Renal Outcomes Watch now
Real-World Data for CV and Renal Outcomes in Diabetic Kidney Disease Watch now
Acute eGFR Dips and Disease Severity on Effects of Empagliflozin for Kidney Outcomes Watch now
Switching from Steroidal Mineralocorticoid Receptor Antagonists to Finerenone in Patients with CKD and T2D Watch now
Albuminuria, eGFR Dip and Disease Severity & Empagliflozin Watch now
Exploring the Margins of Survival Benefit in Deceased Donor Kidney Transplantation Watch now
Treating Obesity in 2025 and Beyond Watch now

Part 2

Highlights

2 sessions
Highlights with Dr Johannes Stegbauer Watch now
Highlights with Dr Kywe Kywe Soe Watch now

Faculty Biographies

David Wheeler

David Wheeler

Professor of Kidney Medicine

David Wheeler is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.

Prof Wheeler is a clinician scientist interested in the complications of chronic kidney disease (CKD), specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated in the development and running of several large-scale clinical trials testing lipid-lowering regimens, calcimimetics, intravenous iron, sodium–glucose co-transporter 2 inhibitors and hypoxia-inducible factor stabilisers in patients with CKD.

Prof Wheeler has also been involved in the development of clinical practice guidelines for several organisations, most recently for Kidney Disease: Improving Global Outcomes (KDIGO). He served as KDIGO co-Chair between 2012 and 2019. His ongoing roles include serving as the National Specialty Lead for the…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.